Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Substance Ranolazine (Atc Code Who: C01Eb18)

AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen Germany has Released a tender for Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Substance Ranolazine (Atc Code Who: C01Eb18) in Pharmaceuticals. The tender was released on Mar 11, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Substance Ranolazine (Atc Code Who: C01Eb18)

Deadline - Apr 30, 2025

GT reference number - 63133212

Product classification - Pharmaceutical products